Virus Latency

Antiviral Agents
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir
Edurne Garcia-Vidal, Marc Castellví, Maria Pujantell, Roger Badia, Antoni Jou, Lucia Gomez, Teresa Puig, Bonaventura Clotet, Ester Ballana, Eva Riveira-Muñoz, José A. Esté
Antiviral Agents
Human Immunodeficiency Virus Type 1 Latency Model for High-Throughput Screening
Sofiya Micheva-Viteva, Annmarie L. Pacchia, Yacov Ron, Stuart W. Peltz, Joseph P. Dougherty
Antiviral Agents
Inhibition of Herpes Simplex Virus Reactivation by Dipyridamole
Richard B. Tenser, Andrew Gaydos, Kathleen A. Hay
Antiviral Agents
Effect of Famciclovir on Herpes Simplex Virus Type 1 Corneal Disease and Establishment of Latency in Rabbits
Jeannette M. Loutsch, Bruno Sainz, Mary E. Marquart, Xiaodong Zheng, Prabakaran Kesavan, Shiro Higaki, James M. Hill, Ruth Tal-Singer
Antiviral Agents
Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study
Alana M. Thackray, Hugh J. Field

Main menu